has been cited by the following article(s):
[1]
|
Serum YKL-40 as a Potential Biomarker for Sepsis in Term Neonates—A Pilot Study
Children,
2023
DOI:10.3390/children10050772
|
|
|
[2]
|
Serum YKL-40 as a Potential Biomarker for Sepsis in Term Neonates—A Pilot Study
Children,
2023
DOI:10.3390/children10050772
|
|
|